Insider Trading & Ownership - Ovid Therapeutics Inc. (OVID)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Ovid Therapeutics Inc.
Goto Prev, 0, 1, 2
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-08-28
Purchase
2020-09-01
9:34 pm
Ovid Therapeutics Inc. OVID LEVIN JEREMY M
CEO
10% Owner
8,488 $5.84 $49,570 5,827,991
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-12-17
Option Award
2020-12-21
4:34 pm
N/A
2030-12-16
Ovid Therapeutics Inc. OVID Daly Timothy
EVP,Finance & Corp. Controller
125,000 $0 125,000
(Direct)
View
2020-10-11
Option Award
2020-10-13
4:46 pm
N/A
2030-10-10
Ovid Therapeutics Inc. OVID Rona Jeffrey A
Chief Business Officer
20,000 $0 20,000
(Direct)
View
2020-10-11
Option Award
2020-10-13
4:41 pm
N/A
2030-10-10
Ovid Therapeutics Inc. OVID Haasner Dirk
SVP, Global Regulatory Affairs
20,000 $0 20,000
(Direct)
View
2020-10-11
Option Award
2020-10-13
4:38 pm
N/A
2030-10-10
Ovid Therapeutics Inc. OVID Perone Thomas Michael
General Counsel, Secretary
20,000 $0 20,000
(Direct)
View
2020-09-30
Option Award
2020-10-02
9:40 pm
N/A
2030-09-29
Ovid Therapeutics Inc. OVID Rona Jeffrey A
Chief Business Officer
325,000 $0 325,000
(Direct)
View
Goto Prev, 0, 1, 2